| “Virtual fragment linking”: an approach to identify potent binders from low affinity fragment hits TJ Crisman, A Bender, M Milik, JL Jenkins, J Scheiber, SCK Sukuru, ... Journal of medicinal chemistry 51 (8), 2481-2491, 2008 | 45 | 2008 |
| 36P A point mutation replacing cysteine with arginine at position 382 (C382R) in the transmembrane domain of FGFR2 leads to response to FGF2-inhibitor pemigatinib in chemo … LC Hempel, C Lapa, A Gaumann, JV de Oliveira, J Scheiber, P Philipp, ... Annals of Oncology 33, S17, 2022 | | 2022 |
| A new promising oncogenic target (p. C382R) for treatment with pemigatinib in patients with cholangiocarcinoma L Hempel, C Lapa, A Dierks, A Gaumann, J Scheiber, ... Therapeutic Advances in Medical Oncology 14, 17588359221125096, 2022 | 4 | 2022 |
| Alignment-free 4D-QSAR: Applying the XMAP technique in prospective analyses J Scheiber, C Enzensperger, J Lehmann, N Stiefl, K Baumann QSAR & Molecular Modeling in Rational Design of Bioactive Molecules, 2006 | 2 | 2006 |
| Analysis of pharmacology data and the prediction of adverse drug reactions and off‐target effects from chemical structure A Bender, J Scheiber, M Glick, JW Davies, K Azzaoui, J Hamon, L Urban, ... ChemMedChem: Chemistry Enabling Drug Discovery 2 (6), 861-873, 2007 | 391 | 2007 |
| Assisting drug dosing in pediatrics A Pospiech, M Zilker, J Scheiber, U Holzgrabe, P Högger Pharmacopsychiatry 47 (06), A18, 2014 | | 2014 |
| Aziridide‐Based Inhibitors of Cathepsin L: Synthesis, Inhibition Activity, and Docking Studies R Vicik, M Busemann, C Gelhaus, N Stiefl, J Scheiber, W Schmitz, ... ChemMedChem: Chemistry Enabling Drug Discovery 1 (10), 1126-1141, 2006 | 70 | 2006 |
| Backtranslating clinical knowledge for use in cheminformatics—What is the potential? J Scheiber Bioorganic & medicinal chemistry 20 (18), 5461-5463, 2012 | 1 | 2012 |
| Bridging chemical and biological data: implications for pharmaceutical drug discovery JL Jenkins, J Scheiber, D Mikhailov, A Bender, A Schuffenhauer, ... Computational Approaches in Cheminformatics and Bioinformatics, 25-56, 2012 | 3 | 2012 |
| Charge interactions do the job: a combined statistical and combinatorial approach to finding artificial receptors for binding tetrapeptides in water C Schmuck, M Heil, J Scheiber, K Baumann Angewandte Chemie International Edition 44 (44), 7208-7212, 2005 | 46 | 2005 |
| Chemical Structure Search for Text Corpora “ MN Bux, J Scheiber, M Romacker | | |
| Chemogenomic analysis of safety profiling data J Scheiber, JL Jenkins Chemogenomics: Methods and Applications, 207-223, 2009 | 11 | 2009 |
| CINF 62-New insights into membrane permeability gained from statistical models trained on high content screening, Caco-2 and passive permeability assay data SCK Sukuru, M Glick, S Tilton, J Scheiber, JL Jenkins, JW Davies ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 236, 2008 | | 2008 |
| Cis‐Configured Aziridines Are New Pseudo‐Irreversible Dual‐Mode Inhibitors of Candida albicans Secreted Aspartic Protease 2 B Degel, P Staib, S Rohrer, J Scheiber, E Martina, C Büchold, K Baumann, ... ChemMedChem: Chemistry Enabling Drug Discovery 3 (2), 302-315, 2008 | 38 | 2008 |
| COMP 34-Using a network pharmacology approach to better understand adverse drug reactions J Scheiber, JL Jenkins, D Mikhailov, SCK Sukuru, S Whitebread, J Hamon, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 236, 2008 | | 2008 |
| COMP 495-Tautomers, conformers, and computation of chemical similarity JH Nettles, JL Jenkins, Z Deng, A Bender, J Scheiber, JW Davies, M Glick ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 234, 2007 | | 2007 |
| COMP 86-" Virtual Fragment Linking": An approach to identify potent binders from low affinity fragment hits TJ Crisman, A Bender, M Milik, JL Jenkins, J Scheiber, SCK Sukuru, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 236, 2008 | | 2008 |
| Comparison of cyclodextrin‐dipeptide inclusion complexes in the absence and presence of urea by means of capillary electrophoresis, nuclear magnetic resonance and molecular … B Waibel, J Scheiber, C Meier, M Hammitzsch, K Baumann, GKE Scriba, ... European journal of organic chemistry 2007 (18), 2921-2930, 2007 | 28 | 2007 |
| Cover Picture: Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure (ChemMedChem 6/2007) A Bender, J Scheiber, M Glick, JW Davies, K Azzaoui, J Hamon, L Urban, ... ChemMedChem: Chemistry Enabling Drug Discovery 2 (6), 733-733, 2007 | 3 | 2007 |
| Cover Picture: Comparison of Cyclodextrin‐Dipeptide Inclusion Complexes in the Absence and Presence of Urea by Means of Capillary Electrophoresis, Nuclear Magnetic Resonance … B Waibel, J Scheiber, C Meier, M Hammitzsch, K Baumann, GKE Scriba, ... European Journal of Organic Chemistry 2007 (18), 2895-2895, 2007 | 1 | 2007 |
Jeremy L. JenkinsUS Head Discovery Sciences, Novartis BioMedical Research在 novartis.com 的电子邮件经过验证
